Interventional Radiology Products Market Size, Share and Trends Report 2026 to 2035
What is Interventional Radiology Products Market Size?
Interventional Radiology Products Market Size is valued at 28.80 Billion in 2025 and is predicted to reach 53.86 Billion by the year 2035 at a 6.9% CAGR during the forecast period for 2026 to 2035.
Interventional Radiology Products Market Size, Share & Trends Analysis Report By Type (Catheters, Stents, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Angioplasty Balloons, Other Interventional Radiology Products), By Procedure, By Application, By Region, And By Segment Forecasts, 2026 to 2035
Interventional Radiology Products Market Key Takeaways:
|
Interventional radiology is a medical speciality that focuses on using minimally invasive image-guided techniques to diagnose and treat patients. Radiological guidance systems and technologies such as x-ray, MRI, CT, fluoroscopy, and other modalities are employed in this medical specialty. The most common interventional radiological procedures conducted using these technologies are for the diagnosis of any underlying illnesses that the patient may have, which can be discovered by photography visualization. Interventional radiology is sometimes known as vascular radiology or interventional radiology (VIR). The increased prevalence of chronic diseases such as heart disease and cancer among the global population will act as the main driver, propelling the market forward. Consumer demand for minimally invasive procedures will drive up demand for interventional radiology technologies, including CT scans, MRIs, and ultrasounds, resulting in a quicker market growth rate. The growing focus on the development of innovative/digital inhalers is another major factor driving market expansion.
Furthermore, rising healthcare costs and growing demand for painless drug administration are two significant aspects that will propel the market forward. Similarly, as the number of applications grows, the market's growth rate accelerates. Rapid urbanization, changing lifestyles, and increased disposable incomes in developing and developed countries will influence the rate of growth of the interventional radiology products market. The market for interventional radiology devices would benefit from an increase in the senior population as well as good reimbursement circumstances. On the other side, the high costs of digital radiology instruments such as CT scanners, X-ray systems, and MRI scanners will stifle industry growth. High radiation exposure and tough competition among market competitors will also pose challenges to the interventional radiology products market. Furthermore, a lack of trained workers and a lack of information will break down the market's growth rate, delaying it.
Market Segmentation:
The Interventional Radiology Products market is categorized on the basis of Type, Procedure and application. Based on type, the market is segmented as Catheters, Stents, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Angioplasty Balloons, Thrombectomy Systems, Embolization Devices, Biopsy Needles, Accessories, and Other Interventional Radiology Products. On the basis of Procedure market is segmented into Angioplasty, Angiography, Embolization, Thrombolysis, Biopsy & Drainage, Vertebroplasty, Nephrostomy, and Other Procedures. By applications, the market is segmented into Cardiology, Urology & Nephrology, Oncology, Gastroenterology, Neurology, Orthopedics, and Other Applications.
Based on Applications, the cardiology segment is accounted as a major contributor in the Interventional Radiology Products Market
Cardiology, Urology & Nephrology, Oncology, Gastroenterology, Neurology, Orthopedics, and Other Applications are the market segments based on application. In 2019, the cardiology segment dominated the market. Cardiology problems are becoming increasingly common in the adult and geriatric populations. As patients grow older, the need for high-quality care to treat this illness grows as well. As a result, a number of countries are working to improve access to interventional radiology treatment.
The Stents Segment Witnessed Growth At A Rapid Rate.
The market is segmented based on type: Catheters, Stents, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Angioplasty Balloons, Thrombectomy Systems, Embolization Devices, Biopsy Needles, Accessories, and Other Interventional Radiology Products. Stents dominate the interventional radiology product market. The expanding incidence of cardiac illnesses and cancer, as well as the increasing number of angioplasty operations, performed globally, are responsible for the considerable share of this category.
The North America Interventional Radiology Products Market Holds A significant Revenue Share In The Region.
In 2019, North America was the most important regional market for the market. The region's substantial market share is due to a high prevalence of chronic diseases, a growing elderly population, an increase in the usage of minimally invasive procedures, and the existence of prominent companies in the region. On the other hand, the interventional radiology products market in the Asia Pacific is estimated to grow at the quickest CAGR during the forecast period. The rising prevalence of chronic diseases, the growing demand for quality medical care, rising healthcare spending and government initiatives, increasing disposable income, growth in the medical device industry, and improvements in healthcare infrastructure in Southeast Asian countries are all significant factors driving the Asia Pacific market's growth.
Competitive Landscape
Some major key players in the Interventional Radiology Products Market:
- Medtronic (Ireland),
- Boston Scientific Corporation (US),
- Becton, Dickinson and Company (US),
- Abbott (US),
- Cardinal Health (US),
- Braun Melsungen AG (Germany),
- Stryker (US),
- Terumo Medical Corporation (Japan),
- Cook Medical (US),
- Biosensors International Group, Ltd. (Singapore),
- Teleflex Incorporated (US),
- iVascular S.L.U. (Spain),
- Penumbra, Inc. (US),
- BIOTRONIK SE & Co. KG (Germany),
- ENDOCOR GmbH (Germany),
- Meril Life Sciences Pvt. Ltd. (India),
- Palex Medical (Spain),
- UreSil, LLC (US),
- Alvimedica (Turkey),
- Cardionovum GmbH (Germany),
- SMT (India),
- Medinol Ltd. (Israel),
- Comed B.V. (Netherlands),
- SCITECH (Brazil),
- Balton Sp. z o.o. (Poland),
- Rontis (Switzerland),
- other prominent players
Interventional Radiology Products Market Report Scope
| Report Attribute | Specifications |
| Market size value in 2025 | USD 28.80 Billion |
| Revenue forecast in 2035 | USD 53.86 Billion |
| Growth rate CAGR | CAGR of 6.9% from 2026 to 2035 |
| Quantitative units | Representation of revenue in US$ Million and CAGR from 2026 to 2035 |
| Historic Year | 2022 to 2025 |
| Forecast Year | 2026-2035 |
| Report coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments covered | By Type, By Procedure, By Application |
| Regional scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; South Korea; South East Asia |
| Competitive Landscape | Medtronic (Ireland), Boston Scientific Corporation (US), Becton, Dickinson and Company (US), Abbott (US), Cardinal Health (US), B. Braun Melsungen AG (Germany), Stryker (US), Terumo Medical Corporation (Japan), Cook Medical (US), Biosensors International Group, Ltd. (Singapore), Teleflex Incorporated (US), iVascular S.L.U. (Spain), Penumbra, Inc. (US), BIOTRONIK SE & Co. KG (Germany), ENDOCOR GmbH (Germany), Meril Life Sciences Pvt. Ltd. (India), Palex Medical (Spain), UreSil, LLC (US), Alvimedica (Turkey), Cardionovum GmbH (Germany), SMT (India), Medinol Ltd. (Israel), Comed B.V. (Netherlands), SCITECH (Brazil), Balton Sp. z o.o. (Poland), Rontis (Switzerland), and other prominent players |
| Customization scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing and available payment methods | Explore pricing alternatives that are customized to your particular study requirements. |
Segmentation of Global Interventional Radiology Products Market-
By Type-
- Catheters
- Stents
- Inferior Vena Cava (IVC) Filters
- Hemodynamic Flow Alteration Devices
- Angioplasty Balloons
- Thrombectomy Systems
- Embolization Devices
- Biopsy Needles
- Accessories
- Other Interventional Radiology Products
By Procedure-
- Angioplasty
- Angiography
- Embolization
- Thrombolysis
- Biopsy & Drainage
- Vertebroplasty
- Nephrostomy
- Other Procedures
By Applications-
- Cardiology
- Urology & Nephrology
- Oncology
- Gastroenterology
- Neurology
- Orthopedics
- Other Applications
By Region-
North America-
- The US
- Canada
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Medtronic (Ireland), Boston Scientific Corporation (US), Becton, Dickinson and Company (US), Abbott (US), Cardinal Health (US), B. Braun Melsungen AG
Interventional Radiology Products Market Size is valued at 28.80 Billion in 2025 and is predicted to reach 53.86 Billion by the year 2035
The Interventional Radiology Products Market is expected to grow at a 6.9% CAGR during the forecast period for 2026 to 2035.
Interventional Radiology Products market is categorized on the basis of Type, Procedure and application.
North America is leading the Interventional Radiology Products market.